ETIDIOH - NEW: pandemic influenza

Showing posts with label pandemic influenza. Show all posts

Saturday, May 23, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 23 '26)

Ann Intern Med

ALBALOUL H, Nemer A, Saini N, Schuster MG, et al
Infectious Diseases: What You May Have Missed in 2025.
Ann Intern Med. 2026 Apr 14:e2600983. doi: 10.7326/ANNALS-26-00983.
PubMed Abstract available

REIS G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, et al
The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.
Ann Intern Med. 2026 Mar 31. doi: 10.7326/ANNALS-25-03959.
PubMed Abstract available

MILLER M, Fischer S, Azrael D
Firearm Acquisition and New Exposure to Household Firearms After the Initial Pandemic Purchasing Surge: Results From the 2024 National Firearms Survey.
Ann Intern Med. 2026;179:637-644.
PubMed Abstract available

QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05485.
PubMed Abstract available

MOSER ITK, Dobrescu AI, Sommer I, Goeschl S, et al
Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05536.
PubMed Abstract available

QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
COVID-19 Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
PubMed Abstract available

DOBRESCU A, Pinte L, Sharifan A, Gadinger A, et al
Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05044.
PubMed Abstract available

Antiviral Res

PAGLIARI M, Lutken C, Vianello L, Mazzacan E, et al
LTX-109 as a broad-spectrum antiviral: in vitro and in vivo efficacy against SARS-CoV-2 and Influenza Viruses.
Antiviral Res. 2026 May 19:106444. doi: 10.1016/j.antiviral.2026.106444.
PubMed Abstract available

WANG W, Yang F, Liu K, Cai M, et al
A mouse model of human-derived H10N3 influenza enables preclinical evaluation of antiviral efficacy.
Antiviral Res. 2026 May 18:106436. doi: 10.1016/j.antiviral.2026.106436.
PubMed Abstract available

J Gen Virol

SASVARI H, Sherry L, Logan N, Dunbar D, et al
Serological response to feline coronavirus in the UK domestic cat population.
J Gen Virol. 2026;107:002270.
PubMed Abstract available

J Immunol

SAIDU A, Crawford JC, Walden S, Qu JH, et al
Highly focused human CD8+ T-cell response in the lower airways during acute influenza infection.
J Immunol. 2026;215:vkag068.
PubMed Abstract available

J Infect

SMITH CS, Mohmand Z, Hrycyshyn A, Djerboua M, et al
Risk of severe influenza in people with a history of injection drug use in Ontario: A population-based nested case control study.
J Infect. 2026 May 20:106764. doi: 10.1016/j.jinf.2026.106764.
PubMed Abstract available

J Virol

BAYUROVA E, Kostyushev D, Tikhonov A, Chulanov V, et al
Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics.
J Virol. 2026 Mar 23:e0007726. doi: 10.1128/jvi.00077.
PubMed Abstract available

POZHIDAEVA A, Hoch JC, Pustovalova Y
The DMV pore-forming TM2-Y region of SARS-CoV-2 nsp3 exhibits structural conservation beyond the coronavirus family.
J Virol. 2026 Apr 3:e0203825. doi: 10.1128/jvi.02038.
PubMed Abstract available

RAHEJA H, Sahu R, Ghosh T, Paul S, et al
HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.
J Virol. 2026 Apr 16:e0027626. doi: 10.1128/jvi.00276.
PubMed Abstract available

SALISCH F, Muller-Ruttloff C
Behind the membranous curtain-lipid dynamics and functions in coronaviral replication.
J Virol. 2026 Apr 21:e0175325. doi: 10.1128/jvi.01753.
PubMed Abstract available

GUO D, Yu S, Ma K, Tao H, et al
Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity.
J Virol. 2026 Apr 27:e0167925. doi: 10.1128/jvi.01679.
PubMed Abstract available

NASIR A, Lee D, Avena LE, Berrueta DM, et al
Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.
J Virol. 2026 Apr 27:e0022526. doi: 10.1128/jvi.00225.
PubMed Abstract available

CHEN L, Su H, Shang W, Nie T, et al
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.
J Virol. 2026 Apr 27:e0222325. doi: 10.1128/jvi.02223.
PubMed Abstract available

KOTANI N, Iwasa K, Amimoto T, Yamashita C, et al
Pseudovirus-mediated proximity labeling identifies candidate host cell membrane proteins involved in viral attachment.
J Virol. 2026 Apr 29:e0050726. doi: 10.1128/jvi.00507.
PubMed Abstract available

PLoS Comput Biol

KLOCHKOV KA, Kozlov IE, Ilina EN, Manolov AI, et al
Human mobility and outbreak origins in epidemic spread: Insights from agent-based modeling.
PLoS Comput Biol. 2026;22:e1014279.
PubMed Abstract available

PLoS One

EL KHATIB Y, Mukhamedova F
An alternative strategy for balancing profit maximization and risk reduction.
PLoS One. 2026;21:e0348577.
PubMed Abstract available

LINDAHL YL, Noren H, Engstrom AH, Grandahl M, et al
A solo journey in the shadow of a double-edged pandemic: A qualitative study of women's experience of being pregnant during the COVID-19 pandemic.
PLoS One. 2026;21:e0349378.
PubMed Abstract available

RAUT B, Palla G, Wang J, Campbell S, et al
ThermiQuant AquaStream: A portable instrument for quantitative colorimetric isothermal nucleic acid amplification reactions in paper and tube formats.
PLoS One. 2026;21:e0348607.
PubMed Abstract available

VISKUPIC F, Daly R, Wiltse DL, Gonda M, et al
The relationship between personal COVID-19 vaccination decisions and cattle vaccination practices: Evidence from a survey of South Dakota beef producers.
PLoS One. 2026;21:e0349234.
PubMed Abstract available

LENARZ AM, Park H, Roberts MT, Pan A, et al
The impact of COVID-19 on longevity trends and disparities among Native Americans and Whites in the Four Corners States.
PLoS One. 2026;21:e0347924.
PubMed Abstract available

WILLIAMS H, Armstrong M, Alexander R, Groner J, et al
Dual pandemic of firearm injury and COVID-19 in Central and Southeastern Ohio: An interrupted time series analysis.
PLoS One. 2026;21:e0335813.
PubMed Abstract available

GONGORA-BENDEZU JA, Martinez-Lopez MV, Aguinaga-Fernandez AD, Yovera-Aldana M, et al
Post-COVID spirometric abnormalities in workers with intermittent high-altitude exposure: A cross-sectional study in Peru.
PLoS One. 2026;21:e0329054.
PubMed Abstract available

RIOS MONTOYA V, Suarez Alarcon AY, Perez Castillo S, Zamudio Raez T, et al
Beyond coverage: Can vaccination reduce child mortality despite structural inequality? A global ecological analysis of routine childhood immunization (2010-2023).
PLoS One. 2026;21:e0340756.
PubMed Abstract available

KOO H, Morrow CD
Shared autonomous HERV loci transcription identifies a unique circulating CD14+-xCR1+ mononuclear cell phenotype in a patient group with post-acute sequelae of COVID-19.
PLoS One. 2026;21:e0349350.
PubMed Abstract available

SHOJI M, Nakaoka K, Ishikawa M, Kasai Y, et al
Correction: Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase.
PLoS One. 2026;21:e0349522.
PubMed Abstract available

LIN J, Chen J, Wan L, He W, et al
Computational models for the classification of antibody specificity using heavy chain features.
PLoS One. 2026;21:e0349143.
PubMed Abstract available

DENG Y, Tang Z, Chen Q, Hu X, et al
Computational biology exposed a common pathogenic mechanism in influenza A and Guillain-Barre syndrome.
PLoS One. 2026;21:e0349687.
PubMed Abstract available

ARINAITWE J, Bakamutumaho B, Mugenyi L, Kiwanuka N, et al
The epidemiology of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus circulation among adult patients with acute respiratory illness in Kampala Metropolitan Area in Uganda.
PLoS One. 2026;21:e0344869.
PubMed Abstract available

Proc Natl Acad Sci U S A

Correction for Corell-Escuin et al., Dermcidin has antiviral activity and protects against influenza.
Proc Natl Acad Sci U S A. 2026;123:e2613956123.
PubMed

OZA AN, O'Brien KM, Gleeson JP
Detecting changepoints in dynamical systems: Modeling time-varying transmission of seasonal influenza.
Proc Natl Acad Sci U S A. 2026;123:e2533861123.
PubMed Abstract available

Vaccine

TANG YS, Chen C, Lv H, Sun Y, et al
Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.
Vaccine. 2026;83:128634.
PubMed Abstract available

UKAH UV, Haapala JL, Benitez GV, DeSilva MB, et al
Language and racial disparities in COVID-19 vaccination during pregnancy and lactation.
Vaccine. 2026;83:128638.
PubMed Abstract available

PAUL KK, Torres M, Shih STF, Gray RT, et al
Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis.
Vaccine. 2026;83:128644.
PubMed Abstract available

TUITE AR, Forbes N, Salvadori MI, Tunis M, et al
Cost-effectiveness of ongoing COVID-19 vaccination in the context of high population immunity: A structured review of international economic evidence.
Vaccine. 2026;83:128660.
PubMed Abstract available

HARMA V, Palsola M, Kuusipalo A, Lindh E, et al
Lessons from the 2024 avian influenza vaccination campaign in Finland: a qualitative inquiry.
Vaccine. 2026;86:128736.
PubMed Abstract available

RANQUE B, Galtier F, Nunes H, Le Jeunne C, et al
Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study.
Vaccine. 2026;86:128732.
PubMed Abstract available

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

Saturday, May 16, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 16 '26)

Antiviral Res

PANG L, Zou J, Yuan Z, Zhao P, et al
Repurposing screen using a robust human rhinovirus infectious clone identifies pyrvinium pamoate with antiviral activity.
Antiviral Res. 2026;250:106417.
PubMed Abstract available

Cell

QIAN W, Wei X, Barros AJ, Ye X, et al
Respiratory viral infections prime accelerated lung cancer growth.
Cell. 2026;189:2845-2856.
PubMed Abstract available

Drug Saf

SHETTY AN, Mallard JH, Hennessy D, Wood N, et al
Giant Cell Arteritis Following COVID-19 Vaccination: A Consumer-Stimulated Analysis.
Drug Saf. 2026;49:705-715.
PubMed Abstract available

J Clin Microbiol

SMITH ZR, Godoshian A, Boersma P, Myrick C, et al
Evaluation of self-collection of nasal swab specimens for COVID-19 diagnostic testing in children in the United States, 2020-2023.
J Clin Microbiol. 2026;64:e0133625.
PubMed Abstract available

J Gen Virol

BHAT S, Sadeyen JR, Yang J, Chrzastek K, et al
A G57 (BJ/94-like) H9N2 avian influenza virus exhibits enhanced replication and tissue dissemination in chickens compared with a G1-B virus.
J Gen Virol. 2026;107.
PubMed Abstract available

J Infect Dis

COLDBECK-SHACKLEY RC, Flynn E, Mudhar AK, Taouk ML, et al
Increased Diversity and Introduction of Multidrug-Resistant Strains of Neisseria gonorrhoeae Following Cessation of COVID-19 Pandemic-Related Travel Restrictions: An Observational Genomic Epidemiologic Study.
J Infect Dis. 2026;233:e1130-e1140.
PubMed Abstract available

LUCENA LAGE S, Rocco JM, Oguz C, Otaizo-Carrasquero F, et al
Inflammasome Activation and Oxidative Stress in SARS-CoV-2 Infection and Symptomatic Rebound.
J Infect Dis. 2026;233:e1285-e1297.
PubMed Abstract available

BOECKH M, Xie H, Stevens-Ayers T, Sircy L, et al
Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes.
J Infect Dis. 2025 Dec 31:jiaf649. doi: 10.1093.
PubMed Abstract available

ZHANG R, Shang X, Wang C, Zhou H, et al
Rhinovirus-Associated Lower Respiratory Tract Infection in Hospitalized Adult Patients: A Retrospective Cohort Study.
J Infect Dis. 2026;233:868-876.
PubMed Abstract available

J Virol

XU C, Peng Y, Liu S, Xie R, et al
Cellular hnRNP D promotes influenza A virus replication by inhibiting TBK1-IRF3-mediated innate immune response.
J Virol. 2026 May 13:e0025726. doi: 10.1128/jvi.00257.
PubMed Abstract available

CHEN X, Zheng X, Zhang L, Cai X, et al
Long noncoding RNA#61 synergizes with viral PA-X to augment pyroptosis and attenuate the virulence of highly pathogenic H5N1 influenza virus in mice.
J Virol. 2026 May 12:e0221425. doi: 10.1128/jvi.02214.
PubMed Abstract available

VAN PUL L, Rosendahl Huber SK, Jacobi R, Hendriks M, et al
Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults.
J Virol. 2026 May 12:e0040726. doi: 10.1128/jvi.00407.
PubMed Abstract available

MMWR Morb Mortal Wkly Rep

ROLFES MA, Bauck L, Lipton BA, Margrey SF, et al
Knowledge, Attitudes, and Practices Regarding Avian Influenza Among Owners of Backyard Flocks - United States, July-December 2025.
MMWR Morb Mortal Wkly Rep. 2026;75:234-239.
PubMed Abstract available

N Engl J Med

HAYDEN FG, Shinkai M, Clark TW, Luetkemeyer AF, et al
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.
N Engl J Med. 2026;394:1905-1915.
PubMed Abstract available

PLoS Comput Biol

KIERAN TJ, Maines TR, Belser JA
Limited 'heft' of weight-based outcomes in predicting influenza A virus disease severity in ferrets.
PLoS Comput Biol. 2026;22:e1014210.
PubMed Abstract available

YU G, Garee M, Ventresca M, Yih Y, et al
Modeling individual self-protective behavior during epidemics.
PLoS Comput Biol. 2026;22:e1014252.
PubMed Abstract available

PLoS Med

GOODFELLOW L, Quilty BJ, van Zandvoort K, Edmunds WJ, et al
Social contact patterns in the United Kingdom following the COVID-19 pandemic: The Reconnect cross-sectional survey.
PLoS Med. 2026;23:e1005038.
PubMed Abstract available

PLoS One

ZOUGHEIB Y, Salameh N, Slim A, Wehbi Z, et al
Effect of screen time and outdoor activities on myopia progression.
PLoS One. 2026;21:e0347118.
PubMed Abstract available

YEHIA N, Ibrahim M, Shady RM, Mohamed AAE, et al
Concurrent circulation of avian influenza viruses H5N1 and H9N2 enhances the genetic evolution of reassortant viruses in Egyptian poultry populations.
PLoS One. 2026;21:e0348609.
PubMed Abstract available

CANTON L, Schalkwijk P, Landier J, Rebaudet S, et al
Socioeconomic inequalities and the COVID-19 pandemic in France: Territorial analyzes based on epidemic wave and metropolitan area.
PLoS One. 2026;21:e0348201.
PubMed Abstract available

SUGIYAMA A, Takafuta T, Abe K, Yoshinaga Y, et al
Differences in the long-term course of post-COVID-19 symptoms in adults and children across epidemic periods: A retrospective cohort study in Japan, 2020-2024.
PLoS One. 2026;21:e0348954.
PubMed Abstract available

HUGHES A, Barnard S, Bauer-Staeb C, Holleyman R, et al
Life lost due to the COVID-19 pandemic: A model-based cohort analysis of mortality displacement in the registered population of England.
PLoS One. 2026;21:e0348575.
PubMed Abstract available

LIU Y, Lu E, Ellingson KD, Hollister J, et al
Unveiling post-vaccination proteomic signatures in SARS-CoV-2 infection-naive individuals associated with Omicron breakthrough infections.
PLoS One. 2026;21:e0347602.
PubMed Abstract available

FREITAS EL, Erbisti RS, Grinberg-Weller B, Pinto DCC, et al
Spatiotemporal analysis of psychoactive drug consumption in Brazil during the COVID-19 pandemic.
PLoS One. 2026;21:e0343552.
PubMed Abstract available

TOGEL J, Kuhbandner C
Fear and the internalization of external regulation - An exploratory study on how fear of COVID-19 affected the internalization of mask-wearing.
PLoS One. 2026;21:e0347772.
PubMed Abstract available

MILLER SL, Yan S, Garcia A, Wang LL, et al
Potential airborne transmission of SARS-COV-2 through bathroom ventilation ducts associated with an outbreak in a residential building in Santander, Spain, 2020.
PLoS One. 2026;21:e0345041.
PubMed Abstract available

DOMINGUEZ-MONTERROZA A, Jimenez-Martin A, Mateos Caballero A
Network geometry, topology, and spectral analysis in global stock markets: Insights from using the Ricci curvature, Euler characteristic, and random matrix theory.
PLoS One. 2026;21:e0347767.
PubMed Abstract available

BRAUN J, Kopp J, Kunzi L, Puhan MA, et al
Measurement properties of the 30-second sit-to-stand test in post COVID-19 condition: Results from the PYCNOVID randomised controlled trial.
PLoS One. 2026;21:e0348275.
PubMed Abstract available

LAURENCE J, Smyth E
COVID-19 pandemic stressors and their longer-term association with young people's wellbeing.
PLoS One. 2026;21:e0347875.
PubMed Abstract available

SCHERBOV S, Pothisiri W, Prasitsiriphon O, Ediev DM, et al
Survival and life expectancy inequality by gender in Thai provinces: Trends from 2015 to 2023.
PLoS One. 2026;21:e0348587.
PubMed Abstract available

AZANERO-HARO J, Soto A
Comparison of the performance of four clinical prediction rules for mortality in patients with COVID-19.
PLoS One. 2026;21:e0348683.
PubMed Abstract available

PENG Y
Sustainability-induced loyalty in festival tourism: Examining the mediating pathways between sustainable practices and visitor behavioral support.
PLoS One. 2026;21:e0348506.
PubMed Abstract available

Proc Natl Acad Sci U S A

KEARNS FL, Bogetti AT, Calvo-Tusell C, Braza MKE, et al
D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes.
Proc Natl Acad Sci U S A. 2026;123:e2504793123.
PubMed Abstract available

SIMKO T, Johnson RA
Alleviating administrative burdens in rental assistance promotes access and program efficiency.
Proc Natl Acad Sci U S A. 2026;123:e2512756123.
PubMed Abstract available

Vaccine

CARLOCK MA, Ross TM
Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B/Victoria strains.
Vaccine. 2026;84:128674.
PubMed Abstract available

Virology

WANG R, Chen J, Zhang H, Qin Y, et al
Characterization of monoclonal antibody and identification of two novel linear epitopes on the hemagglutinin protein of H3N2 canine influenza virus.
Virology. 2026;621:110923.
PubMed Abstract available

DING K, Ding Y
H5N1 avian influenza in dairy cattle: Molecular adaptation, transmission mechanisms, and control strategies.
Virology. 2026;621:110927.
PubMed Abstract available

ZHANG Y, Liu L, Chen T, Li M, et al
CD25(+) cell depletion enhances protective immunity of PR8 inactivated influenza vaccine in aged mice.
Virology. 2026;621:110938.
PubMed Abstract available

Giuseppe Michieli

Saturday, May 9, 2026

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, May 9 '26)

Antimicrob Agents Chemother

SULEA T, Stuible M, Moreno M, Pelletier A, et al
Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.
Antimicrob Agents Chemother. 2026;70:e0002426.
PubMed Abstract available

Antiviral Res
CHIBA S, Kiso M, Yamayoshi S, Uraki R, et al
Niclosamide inhibits the replication of highly pathogenic avian influenza A (H5Nx) viruses and antiviral-resistant mutants.
Antiviral Res. 2026;251:106421.
PubMed Abstract available

Cell
HAVENS JL, Kosakovsky Pond SL, Zehr JD, Pekar JE, et al
Dynamics of natural selection preceding human viral epidemics and pandemics.
Cell. 2026;189:2762-2775.
PubMed Abstract available

Epidemiol Infect
MORTON LC, Forshey BM, Klinkhammer KE, Romaner A, et al
Local genomic epidemiology investigations of SARS-CoV-2 during the early pandemic response: A global systematic review.
Epidemiol Infect. 2026;154:e56.
PubMed Abstract available

J Gen Virol
SANTOS IA, Grosche VR, Oliveira LDS, Guarda PHS, et al
Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication.
J Gen Virol. 2026;107:002245.
PubMed Abstract available
ISLAM MT, Pillatzki A, Webb B, Ramamoorthy S, et al
Infectivity of recombinant Torque teno sus virus 1 in pigs coinfected with swine influenza virus.
J Gen Virol. 2026;107:002264.
PubMed Abstract available
SCHAFERS J, Warren CJ, Yang J, Zhang J, et al
Stability of influenza viruses in the milk of cows and sheep.
J Gen Virol. 2026;107:002257.
PubMed Abstract available

J Infect
BEHARIER O, Guedalia J, Sehtman-Shachar DR, Kerem L, et al
Maternal SARS-CoV-2 Infection and Early Child Growth and Development: A Nationwide Cohort Study.
J Infect. 2026 Apr 17:106749. doi: 10.1016/j.jinf.2026.106749.
PubMed Abstract available
PEREZ-MAZZALI M, Perez-Cozar F, Cal-Sabater P, Rybakowska P, et al
Persistent T cell phenotypic alterations and early innate immune dysregulation as potential biomarkers of Long COVID.
J Infect. 2026 Mar 17:106731. doi: 10.1016/j.jinf.2026.106731.
PubMed Abstract available

J Virol
ZHANG L, Hoffmann M, Pohlmann S
Lock out: targeting TMPRSS2 to block influenza and coronaviruses.
J Virol. 2026 May 4:e0080725. doi: 10.1128/jvi.00807.
PubMed Abstract available

MMWR Morb Mortal Wkly Rep
KIBIGER L, Oltean HN, Leitz L, Krause E, et al
Fatal Human Case of Highly Pathogenic Avian Influenza A(H5N5) in a Backyard Flock Owner - Washington, November 2025.
MMWR Morb Mortal Wkly Rep. 2026;75:221-225.
PubMed Abstract available
VAUGHAN A, Joyce A, Traub E, Jae M, et al
Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025.
MMWR Morb Mortal Wkly Rep. 2026;75:215-220.
PubMed Abstract available

N Engl J Med
LITE TL, Goya S, Davis ML, Morris AE, et al
Human Infection with Highly Pathogenic Avian Influenza A(H5N5) Virus.
N Engl J Med. 2026 May 7. doi: 10.1056/NEJMc2518178.
PubMed
LEROUX-ROELS I, Huang G, Ferguson M, Kohli A, et al
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.
N Engl J Med. 2026;394:1803-1813.
PubMed Abstract available

PLoS Biol
CAMPBELL AJ, Shephard M, Paulos AP, Pauly MD, et al
Surveillance on California dairy farms reveals multiple possible sources of H5N1 influenza virus transmission.
PLoS Biol. 2026;24:e3003761.
PubMed Abstract available

PLoS Comput Biol
MCTIERNAN J, Zhang Y, Li S, Kuhlman TE, et al
Clustering of SARS-CoV-2 membrane proteins in lipid bilayer membranes.
PLoS Comput Biol. 2026;22:e1014229.
PubMed Abstract available

PLoS Med
O'HAGAN A, Pechey R, Forde H, Bandy L, et al
Adherence to voluntary UK sugar, salt, and calorie reduction targets in the highest-grossing restaurant chains: A cross-sectional study.
PLoS Med. 2026;23:e1004681.
PubMed Abstract available
KRUK ME, Kapoor NR, Arsenault C, Carai S, et al
Health system use and experience among people with poor mental health: A cross-sectional analysis of the People's Voice Survey in 18 countries.
PLoS Med. 2026;23:e1004745.
PubMed Abstract available

PLoS One
DO NASCIMENTO AI, Dos Santos Conrado D, Mareto LK, de Azevedo MV, et al
Age and vaccine information sources drive vaccine hesitancy: A household survey in Central-Western Brazil.
PLoS One. 2026;21:e0348412.
PubMed Abstract available
SIEBELS K, Ogden NH, Turgeon P, Lapeyre J, et al
The impact of non-pharmaceutical interventions on the socio-economic and demographic determinants of COVID-19 incidence: A spatial analysis of the pandemic in Toronto, Canada.
PLoS One. 2026;21:e0347649.
PubMed Abstract available
CHU L, Hollar TL, Klimas N, Bertolli J, et al
Facilitators of and barriers to participation in Long COVID research: A qualitative analysis.
PLoS One. 2026;21:e0346007.
PubMed Abstract available
WEATHERALD J, Wen C, Sharpe H, Leung WM, et al
Impact of the COVID-19 pandemic on sex-related disparities in cystic fibrosis healthcare utilization and outcomes: A population study.
PLoS One. 2026;21:e0345009.
PubMed Abstract available
BIR C, Jung J, Widmar NO
Understanding why people value working from home or hybrid workplace flexibility a study of preferences during the COVID-19 pandemic.
PLoS One. 2026;21:e0348206.
PubMed Abstract available
KABATA Y, Terauchi R, Nakano T
Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan from 2017 to 2022: An analysis of the NDB Open Data.
PLoS One. 2026;21:e0348087.
PubMed Abstract available
PARK JH, Lee MT, Jung SY, Choi ST, et al
Association between coronavirus disease 2019 and new-onset autoimmune diseases during the early phase of the pandemic.
PLoS One. 2026;21:e0347872.
PubMed Abstract available
TORREJON-GUIRADO MC, Baena-Jimenez MA, Lima-Serrano M
Association between cannabis use and result of COVID-19 testing among scholarised adolescents in Andalusia: A cross-sectional study.
PLoS One. 2026;21:e0347098.
PubMed Abstract available
COSKUNER AKTAS S
Work-family conflict in times of crisis: The moderating roles of self-efficacy and time-based spousal support during pandemic-induced remote work.
PLoS One. 2026;21:e0348368.
PubMed Abstract available

Proc Natl Acad Sci U S A
WAN Z, Yu L, Yang Z, Luo S, et al
Stag2-mediated chromatin dynamics regulates antibody class switch recombination.
Proc Natl Acad Sci U S A. 2026;123:e2536391123.
PubMed Abstract available

Vaccine
BEOGO I, Muray M, Kibret TC, Xu Y, et al
Between racism and rumors: understanding vaccine mistrust among older racially diverse adults in Canada.
Vaccine. 2026;82:128611.
PubMed Abstract available
CONNER TL, Goguet E, Haines-Hull H, Segard A, et al
mRNA COVID-19 vaccination induces minimal IgA in saliva in the absence of prior clinical or subclinical infection.
Vaccine. 2026;82:128612.
PubMed Abstract available
SARNAIK AY, Khan ZU, Rajeswaran T, Majoe A, et al
The role of misinformation in COVID-19 vaccine hesitancy in low- & middle-income countries.
Vaccine. 2026;82:128595.
PubMed Abstract available
PAUL KK, Torres M, Shih STF, Gray RT, et al
Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adults.
Vaccine. 2026;82:128591.
PubMed Abstract available
GULATI RR, Yaqub F, Goodman AL
Enhancing uptake of respiratory vaccinations in asthma and chronic obstructive pulmonary disease (COPD) patients: a systematic review.
Vaccine. 2026;81:128560.
PubMed Abstract available
WU JD, Meng H, Guo XL, Liu L, et al
The immune response of the mRNA vaccine CS-2034 as a heterologous booster before and after breakthrough infection: A follow-up study.
Vaccine. 2026;81:128575.
PubMed Abstract available
HIRAKAWA T, Yamada G, Tokiya M, Furukawa T, et al
Impact of pre-vaccination active vitamin D levels on COVID-19 mRNA vaccine-induced immunity in a Japanese cohort.
Vaccine. 2026;81:128576.
PubMed Abstract available
KONLAN M, Bhandari R, Owusu SA, Kubio C, et al
The effect of the COVID-19 pandemic on routine childhood immunization coverage and dropout: A community-based cross-sectional study in the Tamale Metropolis, Ghana.
Vaccine. 2026;81:128584.
PubMed Abstract available
REYNALDI A, Lee WS, Selva KJ, Audsley J, et al
Immune responses associated with protection from SARS-CoV-2 infection.
Vaccine. 2026;81:128579.
PubMed Abstract available
HIGGINS RA, Mazarakis N, Sun C, Toh ZQ, et al
Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.
Vaccine. 2026;81:128574.
PubMed Abstract available
GASHEMA P, Iradukunda PG, Rudacogora JC, Siddig EE, et al
Unlocking Africa's vaccine Independence: The critical role of technology transfer and intellectual property.
Vaccine. 2026;81:128573.
PubMed Abstract available
HAVERKATE MR, van de Kassteele J, van den Hof S, Sanders JG, et al
The effect of pre-booked appointments on COVID-19 vaccine uptake among previously vaccinated older adults during the 2023 autumn campaign in the Netherlands: a regression discontinuity analysis.
Vaccine. 2026;81:128565.
PubMed Abstract available

Virology
ZHU M, Wang R, Li X, Zhou H, et al
Canine influenza virus at the human-animal interface: origins, adaptive evolution, and implications for public health.
Virology. 2026;621:110943.
PubMed Abstract available
LIU C, Yuan X
Respiratory viruses as key drivers of pulmonary fibrosis: integrated pathways from barrier injury to immune-fibrotic crosstalk.
Virology. 2026;620:110913.
PubMed Abstract available
SULLIVAN-HILL B, Shahrudin S, Ashley CL, Shields NJ, et al
SARS-CoV-2 variant-specific enhancement of dendritic heparan sulfate mimetic antiviral activities.
Virology. 2026;620:110915.
PubMed Abstract available
KIMURA R, Hayashi Y, Fujimoto-Sato Y, Ishii H, et al
Decoding viral evolution through integrative bioinformatics: From genomes to global health.
Virology. 2026;620:110920.
PubMed Abstract available

Virus Res
WANG X, Guo J, Liu J, Jiang J, et al
Shared genetic structure between COVID-19 and migraine: insights from large-scale genome-wide cross-trait analysis.
Virus Res. 2026;367:199708.
PubMed Abstract available
NAGHIBOSADAT M, Hahn E, Molinaro S, Babuadze G, et al
Comparison of SARS-CoV-2 variant pathogenicity in a long-COVID Syrian hamster model.
Virus Res. 2026;367:199711.
PubMed Abstract available
SITHOLE MN, Khan MR, Mohammed HA, Khan RA, et al
A Systematic Review on Vaccine Developmental Approaches: Evaluating Efficacy, and Addressing Challenges of Infectious Diseases in the Post-COVID-19 Era.
Virus Res. 2026 Apr 1:199720. doi: 10.1016/j.virusres.2026.199720.
PubMed Abstract available
LIU Y, Wang C, Yan D, Zhang Y, et al
Prognostic prediction in COVID-19 patients: a comprehensive analysis of gut microbiota and hematological biomarkers.
Virus Res. 2026;367:199729.
PubMed Abstract available

Giuseppe Michieli

Saturday, May 2, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 2 '26)

Biochem Biophys Res Commun

SAKTHI P, Arun K, Priya D
Integrative network pharmacology and molecular simulation analysis reveals the therapeutic potential of Coscinium fenestratum alkaloids against SARS-CoV-2.
Biochem Biophys Res Commun. 2026;817:153681.
PubMed Abstract available

Epidemiol Infect

TOZDUMAN B, Gulle BT
Influenza Vaccination Coverage and Determinants of Vaccination Among Older Adults in Turkey.
Epidemiol Infect. 2026 Apr 30:1-17. doi: 10.1017/S0950268826101563.
PubMed

J Gen Virol

CHIANG HL, Lin HT, Chen WY, Liang KH, et al
Broadly neutralizing monoclonal antibodies derived from mRNA LNP immunization exhibit potent neutralizing ability against JN.1, KP.3.1.1 and XEC new Omicron variants.
J Gen Virol. 2026;107:002251.
PubMed Abstract available

J Immunol

BENEZECH S, Picq L, Villard M, Rousseaux N, et al
Single-cell analysis identifies CPT1a-associated metabolic remodeling in human NK cells during COVID-19.
J Immunol. 2026;215:vkag036.
PubMed Abstract available

J Infect Dis

O'HALLORAN A, Hood N, Ujamaa D, Merced-Morales A, et al
Effects of age and birth cohort on influenza A virus subtype-specific hospitalization rates, United States 2010-2025.
J Infect Dis. 2026 Apr 27:jiag232. doi: 10.1093.
PubMed Abstract available

ISHIKAWA S, Okada N, Fukui Y, Ueha R, et al
Respiratory Syncytial Virus-Mediated Gas6/Axl Axis Induces Hyporesponsive Macrophages to Promote Pneumococcal Proliferation in the Nasopharynx.
J Infect Dis. 2026;233:674-684.
PubMed Abstract available

ESNEAU C, Boettiger D, Leask S, Bryant NE, et al
The Pandemic Respiratory Virus Epidemiological Surveillance Trial - A Self-swab Surveillance System for Respiratory Viruses Nested Within FluTracking.
J Infect Dis. 2026;233:e1031-e1039.
PubMed Abstract available

KLAASSEN F, Swartwood NA, Chitwood MH, Lopes R, et al
National- and State-level SARS-CoV-2 Immunity Trends From January 2020 to December 2023: a Mathematical Modeling Analysis.
J Infect Dis. 2026;233:714-724.
PubMed Abstract available

J Virol

DAINES R, Sadeyen J-R, Chang P, Iqbal M, et al
Mapping hemagglutinin residues driving antigenic diversity in H5Nx avian influenza viruses.
J Virol. 2026 Apr 30:e0009526. doi: 10.1128/jvi.00095.
PubMed Abstract available

Lancet

DU X, Anderson CS
Off-target benefits of influenza vaccination in cardiovascular disease - Authors' reply.
Lancet. 2026;407:1600.
PubMed

FROBERT O, Pedersen IB, Hjelholt AJ, Erikstrup C, et al
Off-target benefits of influenza vaccination in cardiovascular disease.
Lancet. 2026;407:1599-1600.
PubMed

Pediatrics

ENGSTROM EE, Kaplan SL, Barson WJ, Lin PL, et al
Pneumococcal Pneumonia in Hospitalized Children: 2017-2023.
Pediatrics. 2026;157:e2025073196.
PubMed Abstract available

KUTZ C, Alarcon-Andrade G, Aguilera E, Garfias C, et al
Incidence and Severity of Type 1 Diabetes in Children Through the COVID-19 Pandemic in Chile.
Pediatrics. 2026 Apr 23:e2025072191. doi: 10.1542/peds.2025-072191.
PubMed Abstract available

JACOBSON KB, Merchant M, Fireman B, Klein NP, et al
SARS-CoV-2 Vaccination Before and During Pregnancy and Prevention of Infant COVID-19 Infection.
Pediatrics. 2026 Apr 22:e2025073000. doi: 10.1542/peds.2025-073000.
PubMed Abstract available

LOWENSTEIN C, Kamdar N, Rehkopf DH
Trends in Youth Mental Health Among Patients in Family Medicine Practices: 2017-2023.
Pediatrics. 2026;157:e2025072305.
PubMed Abstract available

PLoS Comput Biol

MOSS R, Tobin RJ, O'Hara-Wild M, Adekunle AI, et al
Ensemble forecasts of COVID-19 activity to support Australia's pandemic response: 2020-22.
PLoS Comput Biol. 2026;22:e1014199.
PubMed Abstract available

PAMORNCHAINAVAKUL N, Schroeder DC, VanderWaal K
QoALa: A comprehensive workflow for viral quasispecies diversity comparison using long-read sequencing data.
PLoS Comput Biol. 2026;22:e1014208.
PubMed Abstract available

PLoS One

THIPAYAMASKOMON C, Grimaud O, Tattevin P, Lamhaut L, et al
High-speed trains versus air transport vectors for mass transfers of critically ill patients: The TRANSCOV cohort study.
PLoS One. 2026;21:e0348090.
PubMed Abstract available

HU R, Valdivia A, White T, Ju W, et al
Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19.
PLoS One. 2026;21:e0348065.
PubMed Abstract available

OKADA Y, Nishiura H
Changes in life expectancy and life span equality during the COVID-19 epidemic in 2020-22 in Japan.
PLoS One. 2026;21:e0345579.
PubMed Abstract available

RODRIGUEZ-CRESPO JJ, Gutierrez-Leon E, Dammann-Beltran P, Seaman-Gomez JA, et al
Outcomes in acute pulmonary embolism and their association with adherence to international recommendations around COVID-19 pandemic-induced hospital-strain: The experience in a Mexican tertiary care center.
PLoS One. 2026;21:e0347761.
PubMed Abstract available

HASHEMPOUR Y, Zazouli MA, Jaafarzadeh N, Valadan R, et al
Integrated monitoring of enveloped viruses in hospital environments: Detection, persistence, and implications for infection control.
PLoS One. 2026;21:e0345644.
PubMed Abstract available

SU B, Sun Z, Chen R, Liu H, et al
Association between psychological distress, lifestyle and career planning on health-related quality of life among the university students during school closure of COVID-19 pandemic in China.
PLoS One. 2026;21:e0347032.
PubMed Abstract available

WANG M, Laison EKE, Philippsen T, Ghaemi S, et al
Mechanistic modelling of highly pathogenic avian influenza: A scoping review revealing critical gaps in cross-species transmission models.
PLoS One. 2026;21:e0347929.
PubMed Abstract available

FATHELRAHMAN E, Mohamed Ali M, Challa TG, Osman R, et al
Modeling and assessing Highly Pathogenic Avian Influenza (HPAI) spread, epidemiological control measures, and cost.
PLoS One. 2026;21:e0340004.
PubMed Abstract available

BASHIR K, Ouedraogo MO, Dharma C, Sobers M, et al
Strengthening access to and confidence in COVID-19 vaccines among equity-deserving populations across Canada: An exploratory qualitative study.
PLoS One. 2026;21:e0301953.
PubMed Abstract available

KO CC, Wu JY, Hung KC, Liao SW, et al
The impact of COVID-19 vaccination on long-term risk of new-onset atrial fibrillation/flutter after COVID-19 infection: A retrospective cohort study.
PLoS One. 2026;21:e0348133.
PubMed Abstract available

LIU C, Yang L, Lei J
CMAP-Fusion: A cross-modal feature selection and model pruning framework for laboratory and imaging data.
PLoS One. 2026;21:e0346875.
PubMed Abstract available

DAS N, Konduru L, Dahia SS, Sagnika S, et al
The stress reduction potential of Bhagavad Gita and Yoga for healthcare workers during the COVID-19 pandemic: A randomized controlled trial.
PLoS One. 2026;21:e0347320.
PubMed Abstract available

Proc Natl Acad Sci U S A

RODRIGUEZ HERNANDEZ CJ, Cruz-Cruz A, Shrestha CL, Terekhova M, et al
Gingipain proteases from the bacterium Porphyromonas gingivalis confer protection against airway viral infection.
Proc Natl Acad Sci U S A. 2026;123:e2503100123.
PubMed Abstract available

HUANG KA, Nguyen HTV, Chen YY, Wu KJ, et al
Broad neutralization of influenza B hemagglutinin antibodies via receptor mimicry and glycan engagement.
Proc Natl Acad Sci U S A. 2026;123:e2532989123.
PubMed Abstract available

ZHANG Y, Wang C, Zheng Y, Chen F, et al
An Ad5-vectored platform generating self-assembling VLPs elicits potent mucosal immunity against influenza A virus and SARS-CoV-2.
Proc Natl Acad Sci U S A. 2026;123:e2519857123.
PubMed Abstract available

DE LACY N, Lam WY, Collins T, Danks D, et al
A century of suicide: Insights from long-term data in the United States.
Proc Natl Acad Sci U S A. 2026;123:e2519951123.
PubMed Abstract available

Vaccine

LIU Y, Jia M, Mu X, Jiang B, et al
Designing equitable influenza vaccination services for older adults in rural China: A discrete choice experiment.
Vaccine. 2026;82:128590.
PubMed Abstract available

SILVA LL, Lopes VDS, da Silva DCB, Nemer CRB, et al
Global overview of vaccine trust: Evidence from a scoping review.
Vaccine. 2026;79:128482.
PubMed Abstract available

JAMES E, Christie S, Boye B, Githieya D, et al
How to leverage social media to build confidence in COVID-19 vaccines: findings and lessons learned from nationwide campaigns in four countries.
Vaccine. 2026;79:128475.
PubMed Abstract available

MALDEN DE, Ackerson BK, Gee J, Peryer MA, et al
Self-reported reactogenicity of RSV vaccines among older adults: a post-licensure study within a large integrated healthcare system in Southern California.
Vaccine. 2026;79:128493.
PubMed Abstract available

FANTIN R, Das S, Loria V, Calderon A, et al
Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring study.
Vaccine. 2026;79:128506.
PubMed Abstract available

DENG L, Barton B, Choi P, Clarke L, et al
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.
Vaccine. 2026;79:128501.
PubMed Abstract available

BRIGGS K, Gingerich MC, Gingerich A, Johnson SK, et al
Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and heterologous challenge in mice and hamsters.
Vaccine. 2026;79:128490.
PubMed Abstract available

AZEEZ R, Ames SR, Lotoski LC, Winsor GL, et al
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort.
Vaccine. 2026;79:128342.
PubMed Abstract available

ROOYAKKERS A, Ye L, Cahn PE, Ruiz-Palacios GM, et al
Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trial.
Vaccine. 2026;79:128424.
PubMed Abstract available

STRAUTINS K, Foong R, Carcione D, Spencer P, et al
Post-licensure safety monitoring of nirsevimab in Western Australia 2024.
Vaccine. 2026;79:128468.
PubMed Abstract available

AIZAWA Y, Shobugawa Y, Tachikawa J, Ikuse T, et al
Effectiveness of the COVID-19 messenger RNA vaccine against symptomatic omicron infection in children aged 6 months to 11 years in Japan.
Vaccine. 2026;79:128474.
PubMed Abstract available

LLOYD PC, Shah PB, Zhang HT, Shah N, et al
Safety monitoring of health outcomes following RSVPreF3 + AS01 and RSVPreF vaccination among Medicare beneficiaries aged 65 years and older in the United States, 2023-2024.
Vaccine. 2026;79:128459.
PubMed Abstract available

MADNI SA, Olson CK, Zauche LH, Machefsky A, et al
Risk of perinatal death and preterm birth among an observational cohort of women vaccinated against SARS-CoV-2 in pregnancy: CDC COVID-19 vaccine pregnancy registry.
Vaccine. 2026;79:128461.
PubMed Abstract available

GIOVANATTI A, Shapiro AE
Anticipating tuberculosis vaccine acceptability in Kenya and South Africa: a narrative review of behavioral and social drivers and strategies to optimize acceptability.
Vaccine. 2026;79:128457.
PubMed Abstract available

GUARDALINI LGO, Martins IM, Bernardino TC, Quintilio W, et al
Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens.
Vaccine. 2026;79:128406.
PubMed Abstract available

DURIER C, Benhamouda N, Besbes A, Lefebvre M, et al
Ancestral Wuhan SARS-CoV-2 anti-spike CD4(+) T cells predict protection from symptomatic omicron breakthrough infection.
Vaccine. 2026;79:128425.
PubMed Abstract available

VISKUPIC F, Wiltse DL, Liebl Z, Kinslow T, et al
The prevalence and nature of anti-vaccination legislation in ten midwestern states: Implications for public health and policy.
Vaccine. 2026;79:128452.
PubMed Abstract available

DRISLANE S, Lake J, Attwell K
Learning from government communication strategies to promote infant RSV immunisation: A cross-national study of France, Luxembourg, Spain, and Australia.
Vaccine. 2026;79:128432.
PubMed Abstract available

CABIESES B, Obach A, Madrid P, Blukacz A, et al
Mapping the continuum of COVID-19 vaccine acceptance and hesitancy in Chile: Insights from qualitative research among nationals and migrants.
Vaccine. 2026;79:128433.
PubMed Abstract available

LU PJ, Hung MC, Srivastav A, Kriss JL, et al
RSV vaccination uptake by the end of the 2024-25 respiratory virus season among adults aged 60-74 years at increased risk of severe RSV and adults aged >/=75 years.
Vaccine. 2026;79:128427.
PubMed Abstract available

JANSSEN RS, Coffman RL
A narrative review of immune-mediated adverse events in clinical trials of CpG oligonucleotide toll-like receptor 9 agonists.
Vaccine. 2026;79:128437.
PubMed Abstract available

IRVING SA, Crane B, Daley MF, Dixon BE, et al
2023-2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United States.
Vaccine. 2026;79:128441.
PubMed Abstract available

COSTANTINO V, Notaras A, MacIntyre CR
Long COVID in children in Australia and the potential impact of vaccination.
Vaccine. 2026;79:128442.
PubMed Abstract available

LLANES-KIDDER C, Gaythorpe K, Rawson T
Sociodemographic factors influencing COVID-19 vaccine uptake and dropout rates in England.
Vaccine. 2026;79:128477.
PubMed Abstract available

MCEVOY R, Hervol JR, Zhang Y, Wagner EM, et al
A modified self-controlled case series on mortality risk following primary series doses of COVID-19 vaccines in U.S. Medicare beneficiaries aged 65 years and older.
Vaccine. 2026;79:128460.
PubMed Abstract available

Giuseppe Michieli

Saturday, April 25, 2026

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 25 '26)

Ann Intern Med

LIM SY, Lee J, Chang E, Kwon JS, et al
Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 : A Randomized Clinical Trial.
Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-04883.
PubMed Abstract available

QASEEM A, Obley AJ, Yost J, Abraham GM, et al
Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3).
Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03766.
PubMed Abstract available

SOMMER I, Dobrescu A, Gadinger A, Sharifan A, et al
Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review for the American College of Physicians (Version 3).
Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03691.
PubMed Abstract available

Biochemistry

MEDEIROS-SILVA J, Zhang Y, Hong M
Phosphatidylinositol Interactions with the SARS-CoV-2 Envelope Protein Investigated by Lipid (13)C Labeling and Solid-State NMR.
Biochemistry. 2026;65:1178-1191.
PubMed Abstract available

J Infect

COX SN, Bennett JC, Casto AM, Hoffman KL, et al
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024.
J Infect. 2026 Apr 20:106748. doi: 10.1016/j.jinf.2026.106748.
PubMed Abstract available

J Virol

ZHANG R, Jian X, Zhang Y, Sun Y, et al
The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.
J Virol. 2026 Apr 21:e0000626. doi: 10.1128/jvi.00006.
PubMed Abstract available

YILDIZ S, El Zahed SS, Villalon-Letelier F, Wang Q, et al
Re-engineering segment 8 facilitates generation of a versatile live-attenuated influenza A virus vector platform for secretory protein delivery.
J Virol. 2026 Apr 21:e0034726. doi: 10.1128/jvi.00347.
PubMed Abstract available

KONG W, Zhang J, Song Y, Song J, et al
Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
J Virol. 2026 Mar 30:e0027026. doi: 10.1128/jvi.00270.
PubMed Abstract available

XIU R, Wang Y, Cai W, Wang Q, et al
Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or M(pro) inhibitors.
J Virol. 2026 Mar 30:e0007626. doi: 10.1128/jvi.00076.
PubMed Abstract available

BRENNAN JW, Wang G, Connor S, Wang X, et al
A respiratory syncytial virus trailer sequence modulates viral replication and the generation and propagation kinetics of copy-back defective viral genomes.
J Virol. 2026;100:e0018426.
PubMed Abstract available

ADAM A, Wu W, Jones MC, Hao H, et al
Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through gammadelta T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cells.
J Virol. 2026 Mar 18:e0165825. doi: 10.1128/jvi.01658.
PubMed Abstract available

MMWR Morb Mortal Wkly Rep

BELL JM, Barbre K, Meng L, Lape-Newman B, et al
Influenza Vaccination Coverage Among Nursing Home Residents and Health Care Personnel - United States, 2024-25 Influenza Season.
MMWR Morb Mortal Wkly Rep. 2026;75:195-201.
PubMed Abstract available

N Engl J Med

BUTLER CC, Pinto AD, Harris V, Holmes J, et al
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
N Engl J Med. 2026;394:1583-1594.
PubMed Abstract available

Pediatrics

SEGEV N, Wilson E, Moehlman M, Corathers SD, et al
Unmasking Adrenal Insufficiency: Adrenal Crisis Triggered by Influenza-Associated Encephalitis.
Pediatrics. 2026 Apr 22:e2025072983. doi: 10.1542/peds.2025-072983.
PubMed Abstract available

PLoS Comput Biol

LI Y, Nielsen BF, Levin SA, Te Velthuis AJW, et al
Spatio-temporal modelling of in vitro influenza A virus infection: The impact of defective interfering particles on the type I interferon response.
PLoS Comput Biol. 2026;22:e1014198.
PubMed Abstract available

WHITE LA, Leon TM
Forecastability of infectious disease time series: are some seasons and pathogens intrinsically more difficult to forecast?
PLoS Comput Biol. 2026;22:e1014175.
PubMed Abstract available

PLoS One

ORTEGA-MARTIN E, Alvarez-Galvez J
Understanding quality-of-life patterns in long COVID: How Symptoms and socioeconomic conditions shape patient wellbeing.
PLoS One. 2026;21:e0347743.
PubMed Abstract available

CHAVES SS, Castells VB, Mira-Iglesias A, Puig-Barbera J, et al
Rhinovirus/enterovirus contribution to respiratory-associated hospitalizations in adults during respiratory seasons in Spain: A 6-year prospective study.
PLoS One. 2026;21:e0347659.
PubMed Abstract available

LEE J, Bajiya VP, Jung E
Vaccination scenario-based study on seasonal influenza in Republic of Korea.
PLoS One. 2026;21:e0322686.
PubMed Abstract available

PIRZADA P, Wilde A, Doherty GH, Harris-Birtill D, et al
Understanding older adults' perception, acceptance, and adoption of smart home technologies.
PLoS One. 2026;21:e0345563.
PubMed Abstract available

FANG Z, Xu H, Mu Y
Risk-taking responses to crash experience: Evidence from China.
PLoS One. 2026;21:e0347543.
PubMed Abstract available

GARZA J, Sebastian R, Cover B, Sanchez A, et al
Nicotine dependence among critically ill COVID-19 patients: A population-based cohort study.
PLoS One. 2026;21:e0308776.
PubMed Abstract available

MCDONALD C, Grajales AG, Yahia NA, Fisman D, et al
Healthcare resource utilization and cost burden of COVID-19 according to vaccination status in adults in Ontario, Canada, 2021-2023.
PLoS One. 2026;21:e0344690.
PubMed Abstract available

LOVATO N, Appleton SL, Reynolds AC, Gill TK, et al
Relationships between pre-pandemic mental health, sociodemographic factors and health behaviours in older adults during the acute onset of COVID-19 in Australia: A descriptive analysis.
PLoS One. 2026;21:e0346787.
PubMed Abstract available

AUDUREAU E, Jean C, Layese R, Neuraz A, et al
Association between parenthood and survival among 30,386 patients hospitalized with COVID-19.
PLoS One. 2026;21:e0346679.
PubMed Abstract available

IPEKCI AM, Hodel EM, Filsinger M, Wegmuller S, et al
Who would take part in a pandemic preparedness cohort study? The role of vaccine-related affective polarisation: Cross-sectional survey.
PLoS One. 2026;21:e0346420.
PubMed Abstract available

YANG Z, Imouza A, Puelma Touzel M, Amadoro C, et al
Regional and temporal patterns of partisan polarization during the COVID-19 pandemic in the United States and Canada.
PLoS One. 2026;21:e0347327.
PubMed Abstract available

Proc Natl Acad Sci U S A

SANDERS CG, Liu M, Fusco JA, Ohl EM, et al
Efficient replication of influenza D virus in the human airway underscores zoonotic potential.
Proc Natl Acad Sci U S A. 2026;123:e2530325123.
PubMed Abstract available

Vaccine

ROBERTSON AH, Wolf AS, Fossum E, Solum G, et al
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections.
Vaccine. 2026;80:128511.
PubMed Abstract available

DLOUHY P, Petras M, Lesna IK, Macalik R, et al
Transient elevation of NT-proBNP after mRNA COVID-19 vaccination in healthy adults: A longitudinal biomarker analysis.
Vaccine. 2026;80:128535.
PubMed Abstract available

VAN DE BURGWAL LHM, Pronker ES, Herz J
Australia's vaccine legacy: Time for a boost? Mapping an innovation system in a fragmented data environment.
Vaccine. 2026;80:128525.
PubMed Abstract available

WU D, Liu K
Cost and effectiveness of COVID-19 vaccination strategies during the 2023 post-reopening omicron wave in Xinjiang, Western China: Evidence from SIR and Markov models.
Vaccine. 2026;80:128536.
PubMed Abstract available

MAEDA H, Saito N, Igarashi A, Ishida M, et al
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS.
Vaccine. 2026;80:128544.
PubMed Abstract available

MORO PL, Romanson B, Marquez P, Zhang B, et al
Adverse events after Pfizer's Respiratory Syncytial Virus Vaccine in pregnant women in the Vaccine Adverse Event Reporting System, 2024-2025, United States.
Vaccine. 2026;80:128547.
PubMed Abstract available

QUINTANAR-SOLARES M, Fleming JA, Musau W, Mulati F, et al
RSV ready? Exploring feasibility and acceptability of RSV immunization options in low- and middle-income countries.
Vaccine. 2026;80:128550.
PubMed Abstract available

KITANO T, Hashimoto E, Sado T, Yoshida S, et al
Maternal effectiveness of respiratory syncytial virus using multicenter healthcare records: A retrospective cohort study.
Vaccine. 2026;80:128566.
PubMed Abstract available

ZHANG L, Lin T, Wang M, Ma X, et al
Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial.
Vaccine. 2026;82:128588.
PubMed Abstract available

FOLEGATTI PM, Pepin S, Tabar C, Fries K, et al
Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study.
Vaccine. 2026;82:128582.
PubMed Abstract available

RICE E, Cheng AC, Britton PN, Carr J, et al
Influenza epidemiology, treatment and prevention in Australian children: Trends from 6 years of PAEDS-FluCAN influenza surveillance (2019-2024).
Vaccine. 2026;82:128592.
PubMed Abstract available

Giuseppe Michieli

ETIDIOH - NEW

Saturday, May 23, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 23 '26)

Saturday, May 16, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 16 '26)

Saturday, May 9, 2026

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, May 9 '26)

Saturday, May 2, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, May 2 '26)

Saturday, April 25, 2026

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 25 '26)

My New Space

Most Popular Posts